Regencell Bioscience Holdings RGC
NASDAQ RGC
$10.80 +0.35 (+3.35%)
At close: Oct 21, 2026 · 4:00 PM EDT

Regencell Bioscience Holdings (RGC) Long-Term Deferred Tax (2022 - 2026)

Updated

Analysis

Regencell Bioscience Holdings (RGC) Long-Term Deferred Tax (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Regencell Bioscience Holdings 5.36 Bn 5.33 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 295,620.00
Dec 31, 2025 386,302.00
Jun 30, 2025 544,385.00
Jun 30, 2024 84,780.00
Jun 30, 2023 451,084.00
Jun 30, 2022 747,426.00
API Access

Regencell Bioscience Holdings Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=RGC&period=max&api_key=YOUR_API_KEY